Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients
This study is not yet open for participant recruitment.
Verified April 2013 by Prolong Pharmaceuticals
Sponsor:
Prolong Pharmaceuticals
Information provided by (Responsible Party):
Prolong Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01374165
First received: May 26, 2011
Last updated: April 23, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |